Teriparatide

Teriparatide is a medication used in the management and treatment of osteoporosis. The drug is in the anabolic class of osteoporosis medications. Human parathyroid hormone is a powerful osteoanabolic agent made up of the first 34 Amino acids of the N-terminal. It has undergone multiple clinical trials that proved its safety and efficacy for the treatment of osteoporosis. When under continuous exposure to PTH (eg, hyperparathyroidism), bone undergoes resorption more than formation, while intermittent exposure to low-dose PTH (like daily teriparatide administration) induces bone formation more than resorption.